These findings suggest that CIN development leads to inflammation and ROS production, and changes in the expression levels of NFKB1, SIRT1, and NFE2L2 could predict the risk of CIN in patients. Here, NFE2L2 is linked to cervical squamous intraepithelial neoplasia.